Evaluation of safety and efficacy of erlotinib as monotherapy for Chinese patients with advanced non-small cell lung cancer

被引：0
|
作者：
Zhang, Xiao-Tong [1 ]
Li, Long-Yun [1 ]
Wang, Meng-Zhao [1 ]
Zhang, Li [1 ]
Zhong, Wei [1 ]
Wang, Shu-Lan [1 ]
机构：
[1] Beijing Union Med Coll Hosp, Beijing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：184 / 185
页数：2
相关论文
共 50 条
  • [41] Updated efficacy and safety of pralsetinib in Chinese patients with advanced RET fusion plus non-small cell lung cancer
    Zhou, Q.
    Wu, Y-L.
    Zhao, J.
    Chang, J.
    Wang, H.
    Fan, Y.
    Wang, K.
    Wu, G.
    Nian, W.
    Gong, Y.
    Sun, Y.
    Sun, M.
    Wang, X.
    Shi, H.
    Zheng, X.
    Qin, M.
    Duan, X.
    Shen, Z.
    Yao, S.
    Yang, J.
    ANNALS OF ONCOLOGY, 2022, 33 : S1593 - S1593
  • [42] Efficacy and Toxicity of Erlotinib and Gefitinib in Moroccan Patients with Advanced Non-Small Cell Lung Cancer with EGFR Mutation
    Benchakroun, N.
    Minoungou, N.
    Bouchbika, Z.
    Jouhadi, H.
    Tawfik, N.
    Sahraoui, S.
    Benider, A.
    Acharki, A.
    Lemzah, M.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S953 - S953
  • [43] Comparison of gefitinib and erlotinib for Korean patients with advanced non-small cell lung cancer
    Lee, Jin Hwa
    Jo, You Ri
    Park, Hye Sung
    Ryu, Yon Ju
    Chun, Eun Mi
    Chang, Jung Hyun
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S692 - S692
  • [44] Population pharmacokinetics of erlotinib in Japanese patients with advanced non-small cell lung cancer
    Emoto-Yamamoto, Y.
    Iida, S.
    Kawanishi, T.
    Fukuoka, M.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2015, 40 (02) : 232 - 239
  • [45] Efficacy and safety of domestic and imported gefitinib in patients with advanced non-small cell lung cancer
    Cheng, Huawei
    Liu, Hongyue
    Du, Qiong
    Zhang, Hui
    Zhang, Xiaodan
    Wang, Yangkui
    Shao, Jingjing
    Yang, Feng
    Zhang, Bo
    Shi, Jing
    Liu, Yuguo
    Wu, Nan
    Xu, Silu
    Wei, Qing
    Sun, Yancai
    Zhai, Qing
    Yu, Bo
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (01) : 10 - 15
  • [46] Efficacy and safety of rechallenge treatment with gefitinib in patients with advanced non-small cell lung cancer
    Cappuzzo, Federico
    Morabito, Alessandro
    Normanno, Nicola
    Bidoli, Paolo
    Del Conte, Alessandro
    Giannetta, Laura
    Montanino, Agnese
    Mazzoni, Francesca
    Buosi, Roberta
    Burgio, Marco Angelo
    Cerea, Giulio
    Chiari, Rita
    Cortinovis, Diego
    Finocchiaro, Giovanna
    Foltran, Luisa
    Migliorino, Maria Rita
    Tiseo, Marcello
    Ferrari, Silvia
    De Marinis, Filippo
    LUNG CANCER, 2016, 99 : 31 - 37
  • [47] Efficacy and Safety of WBRT Combined with Endostar in Patients with Advanced Non-Small Cell Lung Cancer
    Dong, Xiaorong
    Zhang, Ruiguang
    Goa, Xican
    Liu, Pian
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S933 - S934
  • [48] EFFICACY AND SAFETY OF CHEMOTHERAPIES FOR ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS WITH INTERSTITIAL PNEUMONIA
    Sakai, M.
    Kubota, T.
    Kawase, S.
    Miyamoto, S.
    Yokoyama, A.
    ANNALS OF ONCOLOGY, 2013, 24 : 82 - 82
  • [49] The efficacy and safety of lcotinib in patients with advanced non-small cell lung cancer: compare with gefitinib
    Zhang, Zhe
    Wang, Qiming
    Tang, Hong
    Xia, Suhua
    He, Zelai
    He, Zhen
    Wang, Lili
    Zhu, Hui
    Li, Shaomei
    Wu, Yufeng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (09): : 18360 - 18366
  • [50] Gefitinib or Erlotinib in the Treatment of Advanced Non-small Cell Lung Cancer
    Shao, Yu-Yun
    Lin, Chia-Chi
    Yang, Chih-Hsin
    DISCOVERY MEDICINE, 2010, 9 (49) : 538 - 545
12345